The Quantikine Mouse Clusterin Immunoassay is a 4.5 hour solid phase ELISA designed to measure mouse Clusterin levels in cell culture supernates, cell lysates, serum, plasma, and urine. It contains NS0-expressed recombinant mouse Clusterin and antibodies raised against the recombinant factor. This immunoassay has been shown to quantitate the recombinant factor accurately. Results obtained us...ing natural mouse Clusterin showed dose-response curves that were parallel to the standard curves obtained using the recombinant kit standards. These results indicate that this kit can be used to determine relative mass values for natural mouse Clusterin.
Clusterin, also known as Apolipoprotein J, Sulfated Glycoprotein 2 (SGP-2), TRPM-2, and
SP-40, is a secreted multifunctional protein that was named for its ability to induce cellular
clustering. It binds a wide range of molecules and may function as a chaperone of misfolded
extracellular proteins. It also participates in the control of cell proliferation, apoptosis, and
carcinogenesis (1, 2). Clusterin is expressed in adult testis, ovary, adrenal gland, liver, heart,
brain, and in many epithelial tissues during embryonic development (3). Mouse Clusterin is
synthesized as a precursor that contains two coiled coil domains, two nuclear localization
signals (NLS), and one heparin binding domain (4-6). Intracellular cleavages of the precursor
remove the signal peptide and generate comparably sized alpha and beta chains which are secreted
as an approximately 80 kDa N-glycosylated and disulfide-linked heterodimer (7-9). Mature
mouse Clusterin shares 77% and 93% amino acid sequence identity with human and rat
Clusterin, respectively.
An alternately spliced 50 kDa isoform of mouse Clusterin (nCLU) remains intracellular and is
neither glycosylated nor cleaved into alpha and beta chains (4). Cellular exposure to ionizing radiation
promotes the translocation of nCLU to the nucleus where it interacts with Ku70 and promotes
apoptosis (4, 10). This function contrasts with the cytoprotective effect of secreted Clusterin
(11). High µg/mL concentrations of Clusterin circulate predominantly as a component of high
density lipoprotein particles, and these are internalized and degraded through interactions
with LRP-2/Megalin (12, 13). The ability of Clusterin to bind and neutralize non-oxidatively
modified LDL reduces cytotoxicity in atherosclerotic plaques (14). The chaperone function
of Clusterin also helps to reduce the accumulation of beta -amyloid fibrils and damage due to
amyloid plaques in Alzheimer's disease (15). Clusterin levels are elevated in the cerebrospinal
fluid of patients with Alzheimer's disease, Parkinson's disease, and multiple sclerosis (9, 16, 17)
and in the urine of patients with kidney injury or bladder cancer (18-20). Clusterin is released
by activated platelets at sites of vascular injury and is found in the synovial fluid of rheumatoid
arthritis and osteoarthritis patients (21, 22). During human tumor progression, nCLU is
downregulated while the secreted form is upregulated and may be aberrantly glycosylated
(10, 23-25). Increased circulating levels of Clusterin enhance tumor aggressiveness by
inhibiting apoptosis and by promoting epithelial to mesenchymal transition (26-28).
⚠ WARNING: This product can expose you to chemicals including N,N-Dimethylforamide, which is known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.
Publications for Clusterin/APOJ (MCLU00)(4)
We have publications tested in 1 confirmed species: Mouse.